SOURCE: Antisoma plc

June 21, 2010 02:12 ET

Antisoma to present at 5th Annual Piper Jaffray Europe Healthcare Conference

LONDON and CAMBRIDGE, MA--(Marketwire - June 21, 2010) -

Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that its CEO, Glyn Edwards, will present at the 5(th) Annual Piper Jaffray Europe Healthcare Conference in London at 1.30 pm local time (08.30 am Eastern time) on Wednesday 23 June.

A webcast of the presentation will be available on Antisoma's website at

For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.

Alison Saville
Senior Marketing and Communications Executive
Antisoma plc
+44 (0)20 3249 2100

Background on Antisoma

Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please for further information about Antisoma.


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

All reproduction for further distribution is prohibited.

Source: Antisoma plc via Thomson Reuters ONE

Contact Information